A number of other research analysts have also recently issued reports on WBA. JPMorgan Chase & Co. cut Walgreens Boots Alliance from an overweight rating to a neutral rating and cut their price objective for the company from $73.00 to $63.00 in a report on Wednesday, October 23rd. Pivotal Research decreased their price target on Walgreens Boots Alliance from $60.00 to $55.00 and set a hold rating for the company in a research note on Wednesday, October 30th. Royal Bank of Canada cut Walgreens Boots Alliance to a hold rating and set a $59.00 target price for the company. in a research note on Friday, September 27th. Cleveland Research reiterated a hold rating on shares of Walgreens Boots Alliance in a report on Monday, September 9th. Finally, Bank of America dropped their price target on Walgreens Boots Alliance from $51.00 to $50.00 and set an underperform rating on the stock in a report on Thursday, October 3rd. Five equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have issued a buy rating to the company’s stock. The company presently has an average rating of Hold and an average target price of $61.35.
NASDAQ:WBA traded up $0.57 on Wednesday, hitting $59.24. The stock had a trading volume of 5,450,000 shares, compared to its average volume of 5,855,335. The company has a quick ratio of 0.36, a current ratio of 0.73 and a debt-to-equity ratio of 0.46. Walgreens Boots Alliance has a 52 week low of $49.03 and a 52 week high of $86.31. The business’s fifty day moving average is $55.10 and its 200 day moving average is $53.53. The company has a market cap of $54.63 billion, a PE ratio of 9.89, a P/E/G ratio of 1.53 and a beta of 0.87.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a dividend of $0.458 per share. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.09%. The ex-dividend date is Friday, November 15th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 30.55%.
In other news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the business’s stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the sale, the chief accounting officer now directly owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 15.73% of the stock is owned by insiders.
Institutional investors and hedge funds have recently made changes to their positions in the company. Caisse DE Depot ET Placement DU Quebec lifted its holdings in Walgreens Boots Alliance by 11.0% in the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,837,465 shares of the pharmacy operator’s stock valued at $647,154,000 after acquiring an additional 1,169,600 shares during the last quarter. Northern Trust Corp lifted its stake in Walgreens Boots Alliance by 0.7% during the second quarter. Northern Trust Corp now owns 11,647,146 shares of the pharmacy operator’s stock valued at $636,750,000 after buying an additional 76,864 shares in the last quarter. Morgan Stanley lifted its position in shares of Walgreens Boots Alliance by 36.2% in the second quarter. Morgan Stanley now owns 4,913,030 shares of the pharmacy operator’s stock worth $268,595,000 after purchasing an additional 1,304,949 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Walgreens Boots Alliance by 2.4% in the second quarter. Charles Schwab Investment Management Inc. now owns 3,794,775 shares of the pharmacy operator’s stock worth $207,461,000 after purchasing an additional 90,568 shares in the last quarter. Finally, Parametric Portfolio Associates LLC lifted its position in shares of Walgreens Boots Alliance by 23.4% in the second quarter. Parametric Portfolio Associates LLC now owns 2,893,195 shares of the pharmacy operator’s stock worth $158,171,000 after purchasing an additional 549,575 shares in the last quarter. 60.60% of the stock is currently owned by hedge funds and other institutional investors.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Further Reading: Swap
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.